BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 26579433)

  • 21. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.
    Wang S; Sheng F; Zou L; Xiao J; Li P
    J Adv Res; 2021 Dec; 34():109-122. PubMed ID: 35024184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway.
    Jung D; York JP; Wang L; Yang C; Zhang A; Francis HL; Webb P; McKeehan WL; Alpini G; Lesage GD; Moore DD; Xia X
    Pflugers Arch; 2014 May; 466(5):1011-9. PubMed ID: 24068255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insufficient bile acid signaling impairs liver repair in CYP27(-/-) mice.
    Meng Z; Liu N; Fu X; Wang X; Wang YD; Chen WD; Zhang L; Forman BM; Huang W
    J Hepatol; 2011 Oct; 55(4):885-95. PubMed ID: 21334403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.
    Watanabe M; Houten SM; Mataki C; Christoffolete MA; Kim BW; Sato H; Messaddeq N; Harney JW; Ezaki O; Kodama T; Schoonjans K; Bianco AC; Auwerx J
    Nature; 2006 Jan; 439(7075):484-9. PubMed ID: 16400329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bile acid signaling and liver regeneration.
    Fan M; Wang X; Xu G; Yan Q; Huang W
    Biochim Biophys Acta; 2015 Feb; 1849(2):196-200. PubMed ID: 24878541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
    Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
    Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
    Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the mechanism of bile acid inhibition of rat sterol 12alpha-hydroxylase gene (CYP8B1) transcription: roles of alpha-fetoprotein transcription factor and hepatocyte nuclear factor 4alpha.
    Yang Y; Zhang M; Eggertsen G; Chiang JY
    Biochim Biophys Acta; 2002 Jun; 1583(1):63-73. PubMed ID: 12069850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bile Acid Homeostasis in a Cholesterol 7α-Hydroxylase and Sterol 27-Hydroxylase Double Knockout Mouse Model.
    Rizzolo D; Buckley K; Kong B; Zhan L; Shen J; Stofan M; Brinker A; Goedken M; Buckley B; Guo GL
    Hepatology; 2019 Jul; 70(1):389-402. PubMed ID: 30864232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids.
    Ferrebee CB; Dawson PA
    Acta Pharm Sin B; 2015 Mar; 5(2):129-34. PubMed ID: 26579438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
    Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice.
    Zhang F; Duan Y; Xi L; Wei M; Shi A; Zhou Y; Wei Y; Wu X
    Chronobiol Int; 2018 May; 35(5):673-690. PubMed ID: 29381405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis.
    Spatz M; Ciocan D; Merlen G; Rainteau D; Humbert L; Gomes-Rochette N; Hugot C; Trainel N; Mercier-Nomé F; Domenichini S; Puchois V; Wrzosek L; Ferrere G; Tordjmann T; Perlemuter G; Cassard AM
    JHEP Rep; 2021 Apr; 3(2):100230. PubMed ID: 33665587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine regulation of human sterol 12alpha-hydroxylase (CYP8B1) gene.
    Jahan A; Chiang JY
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G685-95. PubMed ID: 15550563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
    Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ
    Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
    Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling.
    Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Morretta E; Monti MC; Distrutti E; Fiorucci S
    FASEB J; 2022 Jan; 36(1):e22060. PubMed ID: 34862975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling.
    García-Rodríguez JL; Barbier-Torres L; Fernández-Álvarez S; Gutiérrez-de Juan V; Monte MJ; Halilbasic E; Herranz D; Álvarez L; Aspichueta P; Marín JJ; Trauner M; Mato JM; Serrano M; Beraza N; Martínez-Chantar ML
    Hepatology; 2014 May; 59(5):1972-83. PubMed ID: 24338587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated.
    Xu G; Pan LX; Li H; Shang Q; Honda A; Shefer S; Bollineni J; Matsuzaki Y; Tint GS; Salen G
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G730-5. PubMed ID: 14684380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosis.
    Fu Y; Feng H; Ding X; Meng QH; Zhang SR; Li J; Chao Y; Ji TT; Bi YH; Zhang WW; Chen Q; Zhang YH; Feng YL; Bian HM
    Phytomedicine; 2022 Jul; 101():154120. PubMed ID: 35523117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.